Pulmonary Arterial Hypertension (PAH)

Select from the various topics below and click on the link to get an inside view of how our P&T committee responded to the issue. 

Preferred Tier 4 Agents – Talk of preferring agents within tier 4

Endothelin Agonists vs. PDE-5 – Committee asks specialist what he prefers to use first-line

Community Pulmonologist – Discusses the type of PAH he sees in his patients

Revatio superiority – Revatio superior to other agents in arterial oxygenation and unsure whether this is a class effect

Additional Costs with non-orals – Committee discusses extra considerations for pumps for Flolan and nebulizers for Ventavis

Pipeline – Contracting pharmacist talks new agents and Adcirca

Splitting Tablets – Committee discusses whether there is benefit to splitting tablets and also the cost comparison of Revatio and Adcirca if Adcirca cost is equal Cialis

Comparison of Agents – Committee asks the specialists whether endothelin agonists and PDE-5 agents are similar enough to prefer based on contracting

Right Heart Catheterization – Committee discusses difference between guideline recommendations and what happens in clinical practice


* PTP video clips play in windows media player.  To download click here, Mac users click here. 
 


top of page